prof. dr. W. (Wim) Timens
Professor
E-mail:
w.timens umcg.nl
Field/Discipline
Expertise
Pulmonary pathology
Other positions
- Pathologist
- Board of Trustees Dutch National Tissue Portal
- Board of Trustees CPBT (Centre for Animal-Free Biomedical Translation)
- Member Council Science and Innovation (Federation of Medical Specialists)
- Member Call Advisory Board European Partnership for Personalised Medicine, (EP PerMed)
- Member ZonMW programme committee Post-Covid
- Chair UMCG Cohort and Biobank Coördination Hub
- Biobank coordinator regional Health-RI node UMCG
- Chair Biobank Expert group (SD-CRO), UMCG
- Member Steering group ELSI (Ethical, Legal, Social Implications) Servicedesk
- Member Health Sciences committee National Roadmap Large scale Scientific Infrastructure 2023-2025
- Member national Thymomapanel
- Member Editorial Board J. Pathology
- Member Editorial Board J. COPD
- Co-founder and PI eQTL Lung consortium (collaboration UMC Groningen, UBC, Vancouver, CA, Laval University, Quebec, CA)
- Between 2014-2025: from commercial partners he received honoraria ( all fees to UMCG) for expertise/ scientific advisory board/consultancy/ speakers fee: AbbVie, Astellas, AstraZeneca, Bayer, BMS, Biotest, Boehringer Ingelheim, Chiesi, Diaceutics; GSK, Lilly, MSD/Merck, Novartis, Pfizer, Roche/Ventana, Grants (investigator initiated) from Genentech, MSD/Merck, Roche/Ventana
Last modified:29 October 2025 07.36 a.m.